2d Cerezyme rival available in trials - The Boston Globe
Links shared publicly online about this topic.
- 1,814total visits
2d Cerezyme rival available in trials - The Boston Globe
For the second time in two weeks, federal regulators have moved to counter the ongoing supply shortage of Cerezyme, Genzyme Corp.’s treatment for Gaucher disease, by letting doctors prescribe a rival drug before it has won approval for commercial use.
View full resource at boston.com
Tags: Lipid Storage Disease, Gaucher Disease, Gaucher Disease Medication, Disease and Condition, Drug, FDA, Cerezyme, Genzyme
Most Recently Shared on August 18, 2009 at 1:34 pm By:
Twice in 2 weeks, FDA allows docs to prescribe unapproved Gaucher's drug to make up for shortage of market-leading drug http://tr.im/wBJE
Advertisement
